documents
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
473 rows where docket_id = "FDA-2021-N-1309" sorted by posted_date descending
This data as json, CSV (advanced)
Suggested facets: subtype, posted_date, posted_month, comment_start_date, posted_date (date), comment_start_date (date), comment_end_date (date), last_modified (date)
| id | agency_id | docket_id | title | document_type | subtype | posted_date ▲ | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2021-N-1309-72018 | FDA | None FDA-2021-N-1309 | TAB C 2015-1104 Cigar Flavors PRIA as Cleared by OMB | Supporting & Related Material | Background Material | 2022-09-14T04:00:00Z | 2022 | 9 | 2022-09-14T20:38:50Z | 0 | 0 | 09000064852f7f3a | |||
| FDA-2021-N-1309-72013 | FDA | None FDA-2021-N-1309 | TAB A 2015-1104 Cigar Flavors NPRM as Submitted to OMB | Supporting & Related Material | Background Material | 2022-09-13T04:00:00Z | 2022 | 9 | 2022-09-13T15:46:14Z | 0 | 0 | 09000064852f7f11 | |||
| FDA-2021-N-1309-72015 | FDA | None FDA-2021-N-1309 | TAB B 2015-1104 Cigar Flavors NPRM Track Changes | Supporting & Related Material | Background Material | 2022-09-13T04:00:00Z | 2022 | 9 | 2022-09-13T15:47:36Z | 0 | 0 | 09000064852f7f32 | |||
| FDA-2021-N-1309-72012 | FDA | None FDA-2021-N-1309 | Memorandum to FDA DMS on Cigar Flavors Proposed Rule (Docket No. FDA-2021-N-1309) | Supporting & Related Material | Background Material | 2022-09-13T04:00:00Z | 2022 | 9 | 2022-09-13T15:46:09Z | 0 | 0 | 09000064852f7f0c | |||
| FDA-2021-N-1309-72014 | FDA | None FDA-2021-N-1309 | TAB A 2015-1104 Cigar Flavors PRIA as Submitted to OMB | Supporting & Related Material | Background Material | 2022-09-13T04:00:00Z | 2022 | 9 | 2022-09-13T15:46:24Z | 0 | 0 | 09000064852f7f31 | |||
| FDA-2021-N-1309-72017 | FDA | None FDA-2021-N-1309 | TAB C 2015-1104 Cigar Flavors NPRM as Cleared by OMB | Supporting & Related Material | Background Material | 2022-09-13T04:00:00Z | 2022 | 9 | 2022-09-13T15:50:19Z | 0 | 0 | 09000064852f7f37 | |||
| FDA-2021-N-1309-72016 | FDA | None FDA-2021-N-1309 | TAB B 2015-1104 Cigar Flavors PRIA Track Changes | Supporting & Related Material | Background Material | 2022-09-13T04:00:00Z | 2022 | 9 | 2022-09-13T15:48:57Z | 0 | 0 | 09000064852f7f35 | |||
| FDA-2021-N-1309-72011 | FDA | None FDA-2021-N-1309 | Tribal Consultation Tobacco Product Standards Proposed Rules - Transcript Final | Other | Transcript(s) | 2022-08-18T04:00:00Z | 2022 | 8 | 2022-08-18T04:00:00Z | 2022-08-18T16:22:09Z | 0 | 0 | 090000648524f18a | ||
| FDA-2021-N-1309-71990 | FDA | None FDA-2021-N-1309 | FDA CTP Listening Session Transcript 06/15/2022 | Other | Transcript(s) | 2022-08-05T04:00:00Z | 2022 | 8 | 2022-08-05T04:00:00Z | 2022-08-05T19:11:31Z | 0 | 0 | 090000648521aebc | ||
| FDA-2021-N-1309-71989 | FDA | None FDA-2021-N-1309 | FDA CTP Listening Session Transcript 06/13/2022 | Other | Transcript(s) | 2022-08-05T04:00:00Z | 2022 | 8 | 2022-08-05T04:00:00Z | 2022-08-05T19:09:05Z | 0 | 0 | 090000648521aeba | ||
| FDA-2021-N-1309-50922 | FDA | None FDA-2021-N-1309 | Establishment of Tobacco Product Standards for Menthol in Cigarettes and Characterizing Flavors in Cigars; Extension of Comment Period | Proposed Rule | Extension of Comment Period | 2022-06-21T04:00:00Z | 2022 | 6 | 2022-06-21T04:00:00Z | 2022-06-21T13:16:53Z | 2022-13209 | 0 | 0 | 090000648517e4c9 | |
| FDA-2021-N-1309-29542 | FDA | None FDA-2021-N-1309 | Request for Extension from Spalding Group, Inc. | Other | Request for Extension | 2022-06-08T04:00:00Z | 2022 | 6 | 2022-06-15T04:00:00Z | 2022-06-15T15:25:19Z | 0 | 0 | 090000648514f846 | ||
| FDA-2021-N-1309-29541 | FDA | None FDA-2021-N-1309 | Request for Extension from The National Association of Convenience Stores (NACS), et al. | Other | Request for Extension | 2022-06-03T04:00:00Z | 2022 | 6 | 2022-06-15T04:00:00Z | 2022-06-15T15:22:46Z | 0 | 0 | 090000648512fbd7 | ||
| FDA-2021-N-1309-10937 | FDA | None FDA-2021-N-1309 | Request for Extension from Cheyenne International, LLC | Other | Request for Extension | 2022-05-23T04:00:00Z | 2022 | 5 | 2022-05-26T04:00:00Z | 2022-05-26T14:36:14Z | 0 | 0 | 09000064850d44d9 | ||
| FDA-2021-N-1309-10938 | FDA | None FDA-2021-N-1309 | Request for Extension from Xcaliber International, Ltd., LLC | Other | Request for Extension | 2022-05-23T04:00:00Z | 2022 | 5 | 2022-05-26T04:00:00Z | 2022-05-26T14:35:30Z | 0 | 0 | 09000064850d449f | ||
| FDA-2021-N-1309-0649 | FDA | None FDA-2021-N-1309 | Request for Extension from SWI-DE, LLC d/b/a Drew Estate | Other | Request | 2022-05-19T04:00:00Z | 2022 | 5 | 2022-05-23T04:00:00Z | 2022-05-23T21:27:56Z | 0 | 0 | 0900006485098aeb | ||
| FDA-2021-N-1309-0500 | FDA | None FDA-2021-N-1309 | Request to Close Dockets After 60 Days and Not Extend the Deadline for Comments | Other | Request | 2022-05-16T04:00:00Z | 2022 | 5 | 2022-05-17T04:00:00Z | 2022-05-17T20:47:26Z | 0 | 0 | 0900006485081ba9 | ||
| FDA-2021-N-1309-0489 | FDA | None FDA-2021-N-1309 | Request for Extension from Gibson, Dunn & Crutcher LLP on behalf of Swisher International, Inc. | Other | Request for Extension | 2022-05-12T04:00:00Z | 2022 | 5 | 2022-05-12T04:00:00Z | 2022-05-12T17:47:31Z | 0 | 0 | 09000064850734a3 | ||
| FDA-2021-N-1309-0488 | FDA | None FDA-2021-N-1309 | Request for Extension from National Tobacco Company, LP | Other | Request for Extension | 2022-05-11T04:00:00Z | 2022 | 5 | 2022-05-11T04:00:00Z | 2022-05-12T00:58:27Z | 0 | 0 | 0900006485071c9e | ||
| FDA-2021-N-1309-0485 | FDA | None FDA-2021-N-1309 | Request for Extension from Coalition of Independent Tobacco Manufacturers of America | Other | Request for Extension | 2022-05-11T04:00:00Z | 2022 | 5 | 2022-05-11T04:00:00Z | 2022-05-12T00:42:04Z | 0 | 0 | 090000648507050e | ||
| FDA-2021-N-1309-0479 | FDA | None FDA-2021-N-1309 | Request for Extension from The National Association for Tobacco Outlet, Inc. (NATO) | Other | Request for Extension | 2022-05-10T04:00:00Z | 2022 | 5 | 2022-05-10T04:00:00Z | 2022-05-13T16:56:04Z | 0 | 0 | 09000064850670e9 | ||
| FDA-2021-N-1309-0475 | FDA | None FDA-2021-N-1309 | Request for Withdrawal of Proposed Rule; Request for Extension of The Comment Period | Other | Request | 2022-05-09T04:00:00Z | 2022 | 5 | 2022-05-10T04:00:00Z | 2022-05-12T16:57:15Z | 0 | 0 | 090000648506163b | ||
| FDA-2021-N-1309-0478 | FDA | None FDA-2021-N-1309 | Request for Extension from SMCI Holdings Inc (Swedish Match) | Other | Request for Extension | 2022-05-09T04:00:00Z | 2022 | 5 | 2022-05-10T04:00:00Z | 2022-05-12T16:57:12Z | 0 | 0 | 09000064850643ad | ||
| FDA-2021-N-1309-0477 | FDA | None FDA-2021-N-1309 | Request for Extension from Altria Client Services LLC | Other | Request for Extension | 2022-05-09T04:00:00Z | 2022 | 5 | 2022-05-10T04:00:00Z | 2022-05-12T16:57:08Z | 0 | 0 | 09000064850641ca | ||
| FDA-2021-N-1309-0456 | FDA | None FDA-2021-N-1309 | Request for Extension from ITG Cigars Inc. | Other | Request for Extension | 2022-05-05T04:00:00Z | 2022 | 5 | 2022-05-09T04:00:00Z | 2022-05-09T20:20:04Z | 0 | 0 | 0900006485052f9f | ||
| FDA-2021-N-1309-0457 | FDA | None FDA-2021-N-1309 | Request for Extension from Cigar Association of America, Inc. | Other | Request for Extension | 2022-05-05T04:00:00Z | 2022 | 5 | 2022-05-09T04:00:00Z | 2022-05-10T11:12:26Z | 0 | 0 | 0900006485054940 | ||
| FDA-2021-N-1309-0458 | FDA | None FDA-2021-N-1309 | Request for Extension from Pipe Tobacco Council | Other | Request for Extension | 2022-05-05T04:00:00Z | 2022 | 5 | 2022-05-09T04:00:00Z | 2022-05-10T11:13:27Z | 0 | 0 | 0900006485054979 | ||
| FDA-2021-N-1309-0048 | FDA | None FDA-2021-N-1309 | Reference 45 FDA Scientific Assessment of the Impact of Flavors in Cigar Products 2022 | Supporting & Related Material | Background Material | 2022-05-04T04:00:00Z | 2022 | 5 | 2022-05-04T15:12:08Z | 0 | 0 | 0900006485027101 | |||
| FDA-2021-N-1309-0020 | FDA | None FDA-2021-N-1309 | Reference 17 HHS Preventing Tobacco Use Among Youth and Young Adults 2012 | Supporting & Related Material | Background Material | 2022-05-04T04:00:00Z | 2022 | 5 | 2022-05-04T14:50:40Z | 0 | 0 | 090000648502682f | |||
| FDA-2021-N-1309-0056 | FDA | None FDA-2021-N-1309 | Reference 53 Delnevo Cigar Sales in Convenience Stores 2021 | Supporting & Related Material | Background Material | 2022-05-04T04:00:00Z | 2022 | 5 | 2022-05-04T15:23:11Z | 0 | 0 | 0900006485026d69 | |||
| FDA-2021-N-1309-0051 | FDA | None FDA-2021-N-1309 | Reference 48 Delnevo A Whole Nother Smoke 2007 | Supporting & Related Material | Background Material | 2022-05-04T04:00:00Z | 2022 | 5 | 2022-05-04T15:20:40Z | 0 | 0 | 0900006485027103 | |||
| FDA-2021-N-1309-0097 | FDA | None FDA-2021-N-1309 | Reference 94 Hoffman Flavour Preferences in Youth Versus Adults 2016 | Supporting & Related Material | Background Material | 2022-05-04T04:00:00Z | 2022 | 5 | 2022-05-04T15:51:52Z | 0 | 0 | 0900006485026f4c | |||
| FDA-2021-N-1309-0111 | FDA | None FDA-2021-N-1309 | Reference 108 Rogers Compliance with a Sales Policy on Flavored 2017 | Supporting & Related Material | Background Material | 2022-05-04T04:00:00Z | 2022 | 5 | 2022-05-04T15:58:08Z | 0 | 0 | 09000064850273f2 | |||
| FDA-2021-N-1309-0099 | FDA | None FDA-2021-N-1309 | Reference 96 Chen Levels of Mint and Wintergreen 2010 | Supporting & Related Material | Background Material | 2022-05-04T04:00:00Z | 2022 | 5 | 2022-05-04T15:54:23Z | 0 | 0 | 0900006485026f4e | |||
| FDA-2021-N-1309-0103 | FDA | None FDA-2021-N-1309 | Reference 100 Cantrell Cigar Use Progression 2022 | Supporting & Related Material | Background Material | 2022-05-04T04:00:00Z | 2022 | 5 | 2022-05-04T15:56:21Z | 0 | 0 | 0900006485026f50 | |||
| FDA-2021-N-1309-0108 | FDA | None FDA-2021-N-1309 | Reference 105 Chamberlain Association Between Tobacco Smoking and Cognitive 2012 | Supporting & Related Material | Background Material | 2022-05-04T04:00:00Z | 2022 | 5 | 2022-05-04T15:57:39Z | 0 | 0 | 09000064850273ef | |||
| FDA-2021-N-1309-0112 | FDA | None FDA-2021-N-1309 | Reference 109 Rogers Changes in Cigar Sales 2020 | Supporting & Related Material | Background Material | 2022-05-04T04:00:00Z | 2022 | 5 | 2022-05-04T15:58:19Z | 0 | 0 | 09000064850273f3 | |||
| FDA-2021-N-1309-0116 | FDA | None FDA-2021-N-1309 | Reference 113 Nguyen Intended and Unintended Effects of Restrictions 2015 | Supporting & Related Material | Background Material | 2022-05-04T04:00:00Z | 2022 | 5 | 2022-05-04T15:58:56Z | 0 | 0 | 09000064850274e2 | |||
| FDA-2021-N-1309-0076 | FDA | None FDA-2021-N-1309 | Reference 73 Richter Small Group Discussions on Menthol Cigarettes 2008 | Supporting & Related Material | Background Material | 2022-05-04T04:00:00Z | 2022 | 5 | 2022-05-04T15:35:21Z | 0 | 0 | 0900006485026db6 | |||
| FDA-2021-N-1309-0055 | FDA | None FDA-2021-N-1309 | Reference 52 Gammon Implementation of a Comprehensive Flavoured Tobacco 2021 | Supporting & Related Material | Background Material | 2022-05-04T04:00:00Z | 2022 | 5 | 2022-05-04T15:22:51Z | 0 | 0 | 0900006485026d68 | |||
| FDA-2021-N-1309-0037 | FDA | None FDA-2021-N-1309 | Reference 34 England Developmental Toxicity of Nicotine 2017 | Supporting & Related Material | Background Material | 2022-05-04T04:00:00Z | 2022 | 5 | 2022-05-04T15:04:48Z | 0 | 0 | 09000064850268cf | |||
| FDA-2021-N-1309-0046 | FDA | None FDA-2021-N-1309 | Reference 43 FDA Illicit Trade in Tobacco Products After Implementation 2018 | Supporting & Related Material | Background Material | 2022-05-04T04:00:00Z | 2022 | 5 | 2022-05-04T15:10:50Z | 0 | 0 | 0900006485026d11 | |||
| FDA-2021-N-1309-0015 | FDA | None FDA-2021-N-1309 | Reference 12 FDA Memorandum of Summary of Internal Analysis PATH W5 2021 | Supporting & Related Material | Background Material | 2022-05-04T04:00:00Z | 2022 | 5 | 2022-05-04T14:44:11Z | 0 | 0 | 09000064850269f4 | |||
| FDA-2021-N-1309-0021 | FDA | None FDA-2021-N-1309 | Reference 18 Klein Use of Flavored Cigarettes Among Older Adolescent 2008 | Supporting & Related Material | Background Material | 2022-05-04T04:00:00Z | 2022 | 5 | 2022-05-04T14:51:17Z | 0 | 0 | 0900006485026830 | |||
| FDA-2021-N-1309-0060 | FDA | None FDA-2021-N-1309 | Reference 57 Casseus Cigarette Smokers Classification of Tobacco Products 2016 | Supporting & Related Material | Background Material | 2022-05-04T04:00:00Z | 2022 | 5 | 2022-05-04T15:24:25Z | 0 | 0 | 0900006485026d6e | |||
| FDA-2021-N-1309-0044 | FDA | None FDA-2021-N-1309 | Reference 41 Peterson The Health Equity Framework 2020 | Supporting & Related Material | Background Material | 2022-05-04T04:00:00Z | 2022 | 5 | 2022-05-04T15:09:55Z | 0 | 0 | 0900006485026cfe | |||
| FDA-2021-N-1309-0047 | FDA | None FDA-2021-N-1309 | Reference 44 FDA Final Summary Report External Letter Peer Review 2022 | Supporting & Related Material | Background Material | 2022-05-04T04:00:00Z | 2022 | 5 | 2022-05-04T15:11:36Z | 0 | 0 | 0900006485027100 | |||
| FDA-2021-N-1309-0088 | FDA | None FDA-2021-N-1309 | Reference 85 Avishai Impact and Mechanisms of Cigarillo Flavor 2020 | Supporting & Related Material | Background Material | 2022-05-04T04:00:00Z | 2022 | 5 | 2022-05-04T15:38:02Z | 0 | 0 | 090000648502731e | |||
| FDA-2021-N-1309-0115 | FDA | None FDA-2021-N-1309 | Reference 112 Chaiton Association of Flavoured Cigar Regulations with Wholesale 2019 | Supporting & Related Material | Background Material | 2022-05-04T04:00:00Z | 2022 | 5 | 2022-05-04T15:58:45Z | 0 | 0 | 0900006485027055 | |||
| FDA-2021-N-1309-0093 | FDA | None FDA-2021-N-1309 | Reference 90 Mennella Genetic and Environmental Determinants of Bitter Perception 2005 | Supporting & Related Material | Background Material | 2022-05-04T04:00:00Z | 2022 | 5 | 2022-05-04T15:51:20Z | 0 | 0 | 0900006485027383 | |||
| FDA-2021-N-1309-0159 | FDA | None FDA-2021-N-1309 | Reference 156 Stokes Racial Ethnic Differences in Associations 2021 | Supporting & Related Material | Background Material | 2022-05-04T04:00:00Z | 2022 | 5 | 2022-05-04T16:46:27Z | 0 | 0 | 0900006485027a03 | |||
| FDA-2021-N-1309-0124 | FDA | None FDA-2021-N-1309 | Reference 121 HHS The Health Consequences of Smoking Nicotine Addiction 1988 | Supporting & Related Material | Background Material | 2022-05-04T04:00:00Z | 2022 | 5 | 2022-05-04T16:29:14Z | 0 | 0 | 090000648502751a | |||
| FDA-2021-N-1309-0129 | FDA | None FDA-2021-N-1309 | Reference 126 Lee Inequalities in Tobacco Outlet Density 2017 | Supporting & Related Material | Background Material | 2022-05-04T04:00:00Z | 2022 | 5 | 2022-05-04T16:31:19Z | 0 | 0 | 0900006485027081 | |||
| FDA-2021-N-1309-0150 | FDA | None FDA-2021-N-1309 | Reference 147 Cantrell Marketing Little Cigars and Cigarillos 2013 | Supporting & Related Material | Background Material | 2022-05-04T04:00:00Z | 2022 | 5 | 2022-05-04T16:42:08Z | 0 | 0 | 09000064850270c4 | |||
| FDA-2021-N-1309-0128 | FDA | None FDA-2021-N-1309 | Reference 125 Lee A Systematic Review of Neighborhood Disparities 2015 | Supporting & Related Material | Background Material | 2022-05-04T04:00:00Z | 2022 | 5 | 2022-05-04T16:31:10Z | 0 | 0 | 0900006485027080 | |||
| FDA-2021-N-1309-0148 | FDA | None FDA-2021-N-1309 | Reference 145 Henriksen Neighborhood Variation in the Price of Cheap Tobacco 2017 | Supporting & Related Material | Background Material | 2022-05-04T04:00:00Z | 2022 | 5 | 2022-05-04T16:41:53Z | 0 | 0 | 09000064850270c2 | |||
| FDA-2021-N-1309-0004 | FDA | None FDA-2021-N-1309 | Reference 1 Tynan Consumption of Cigarettes and Combustible Tobacco 2012 | Supporting & Related Material | Background Material | 2022-05-04T04:00:00Z | 2022 | 5 | 2022-05-04T14:32:36Z | 0 | 0 | 0900006485025c56 | |||
| FDA-2021-N-1309-0429 | FDA | None FDA-2021-N-1309 | PRIA Reference 117 Touzani Neuropharmacology of Learned Flavor preferences 2010 | Supporting & Related Material | Background Material | 2022-05-04T04:00:00Z | 2022 | 5 | 2022-05-04T18:36:16Z | 0 | 0 | 0900006485039380 | |||
| FDA-2021-N-1309-0430 | FDA | None FDA-2021-N-1309 | PRIA Reference 118 Palmatier Nicotine Self Administration with Tobacco Flavor 2020 | Supporting & Related Material | Background Material | 2022-05-04T04:00:00Z | 2022 | 5 | 2022-05-04T18:36:40Z | 0 | 0 | 0900006485039387 | |||
| FDA-2021-N-1309-0425 | FDA | None FDA-2021-N-1309 | PRIA Reference 113 Ashley Estimating the Benefits of Public Health Policies 2015 | Supporting & Related Material | Background Material | 2022-05-04T04:00:00Z | 2022 | 5 | 2022-05-04T18:33:47Z | 0 | 0 | 090000648503937d | |||
| FDA-2021-N-1309-0427 | FDA | None FDA-2021-N-1309 | PRIA Reference 115 Massin Measuring Consumer Surplus 2020 | Supporting & Related Material | Background Material | 2022-05-04T04:00:00Z | 2022 | 5 | 2022-05-04T18:35:39Z | 0 | 0 | 090000648503937f | |||
| FDA-2021-N-1309-0408 | FDA | None FDA-2021-N-1309 | PRIA Reference 96 FDA Illicit Trade in Tobacco Products After Implementation 2018 | Supporting & Related Material | Background Material | 2022-05-04T04:00:00Z | 2022 | 5 | 2022-05-04T18:30:52Z | 0 | 0 | 0900006485038e3a | |||
| FDA-2021-N-1309-0426 | FDA | None FDA-2021-N-1309 | PRIA Reference 114 DeCicca Behavioral Welfare Economics 2017 | Supporting & Related Material | Background Material | 2022-05-04T04:00:00Z | 2022 | 5 | 2022-05-04T18:35:32Z | 0 | 0 | 090000648503937e | |||
| FDA-2021-N-1309-0441 | FDA | None FDA-2021-N-1309 | PRIA Reference 129 BLS CPI Data 2022 | Supporting & Related Material | Background Material | 2022-05-04T04:00:00Z | 2022 | 5 | 2022-05-04T18:39:53Z | 0 | 0 | 09000064850393a5 | |||
| FDA-2021-N-1309-0446 | FDA | None FDA-2021-N-1309 | PRIA Reference 134 FDA Tobacco User Fee Assessment Formulation 2020 | Supporting & Related Material | Background Material | 2022-05-04T04:00:00Z | 2022 | 5 | 2022-05-04T18:42:11Z | 0 | 0 | 090000648503998a | |||
| FDA-2021-N-1309-0343 | FDA | None FDA-2021-N-1309 | PRIA Reference 31 Census Annual Survey of State Governments | Supporting & Related Material | Background Material | 2022-05-04T04:00:00Z | 2022 | 5 | 2022-05-04T18:20:50Z | 0 | 0 | 09000064850381f3 | |||
| FDA-2021-N-1309-0364 | FDA | None FDA-2021-N-1309 | PRIA Reference 52 HHS Guidelines for Regulatory Impact Analysis 2016 | Supporting & Related Material | Background Material | 2022-05-04T04:00:00Z | 2022 | 5 | 2022-05-04T18:24:00Z | 0 | 0 | 0900006485038297 | |||
| FDA-2021-N-1309-0356 | FDA | None FDA-2021-N-1309 | PRIA Reference 44 Friedman A Difference in Differences Analysis of Youth Smoking 2021 | Supporting & Related Material | Background Material | 2022-05-04T04:00:00Z | 2022 | 5 | 2022-05-04T18:23:08Z | 0 | 0 | 09000064850382c5 | |||
| FDA-2021-N-1309-0369 | FDA | None FDA-2021-N-1309 | PRIA Reference 57 Ocean Conservancy Together We Are Team Ocean 2020 | Supporting & Related Material | Background Material | 2022-05-04T04:00:00Z | 2022 | 5 | 2022-05-04T18:24:35Z | 0 | 0 | 0900006485038738 | |||
| FDA-2021-N-1309-0384 | FDA | None FDA-2021-N-1309 | PRIA Reference 72 DiFranza Measuring the Loss of Autonomy 2002 | Supporting & Related Material | Background Material | 2022-05-04T04:00:00Z | 2022 | 5 | 2022-05-04T18:27:02Z | 0 | 0 | 090000648503873e | |||
| FDA-2021-N-1309-0316 | FDA | None FDA-2021-N-1309 | PRIA Reference 4 Nonnemaker Mortality and Economic Costs from Regular Cigar Use 2014 | Supporting & Related Material | Background Material | 2022-05-04T04:00:00Z | 2022 | 5 | 2022-05-04T18:15:33Z | 0 | 0 | 0900006485037ca4 | |||
| FDA-2021-N-1309-0317 | FDA | None FDA-2021-N-1309 | PRIA Reference 5 Gentzke Tobacco Product Use Among Middle and High School 2020 | Supporting & Related Material | Background Material | 2022-05-04T04:00:00Z | 2022 | 5 | 2022-05-04T18:15:40Z | 0 | 0 | 0900006485037d45 | |||
| FDA-2021-N-1309-0324 | FDA | None FDA-2021-N-1309 | PRIA Reference 12 HHS Smoking Cessation A Report of the Surgeon General 2020 | Supporting & Related Material | Background Material | 2022-05-04T04:00:00Z | 2022 | 5 | 2022-05-04T18:17:54Z | 0 | 0 | 0900006485037d88 | |||
| FDA-2021-N-1309-0226 | FDA | None FDA-2021-N-1309 | Reference 223 Henderson Menthol Enhances Nicotine Reward Related Behavior 2017 | Supporting & Related Material | Background Material | 2022-05-04T04:00:00Z | 2022 | 5 | 2022-05-04T17:50:40Z | 0 | 0 | 0900006485029ddf | |||
| FDA-2021-N-1309-0229 | FDA | None FDA-2021-N-1309 | Reference 226 Chang Biomarkers of Exposure Among US Adult 2019 | Supporting & Related Material | Background Material | 2022-05-04T04:00:00Z | 2022 | 5 | 2022-05-04T17:51:02Z | 0 | 0 | 0900006485029df2 | |||
| FDA-2021-N-1309-0238 | FDA | None FDA-2021-N-1309 | Reference 235 McCormack Cigar and Pipe Smoking and Cancer Risk 2010 | Supporting & Related Material | Background Material | 2022-05-04T04:00:00Z | 2022 | 5 | 2022-05-04T17:56:21Z | 0 | 0 | 0900006485029e0c | |||
| FDA-2021-N-1309-0259 | FDA | None FDA-2021-N-1309 | Reference 256 Barnoya Cardiovascular Effects of Secondhand Smoke 2005 | Supporting & Related Material | Background Material | 2022-05-04T04:00:00Z | 2022 | 5 | 2022-05-04T17:59:47Z | 0 | 0 | 0900006485029e56 | |||
| FDA-2021-N-1309-0219 | FDA | None FDA-2021-N-1309 | Reference 216 Palmatier Nicotine Self Administration with Tobacco Flavor 2020 | Supporting & Related Material | Background Material | 2022-05-04T04:00:00Z | 2022 | 5 | 2022-05-04T17:45:07Z | 0 | 0 | 09000064850299b7 | |||
| FDA-2021-N-1309-0160 | FDA | None FDA-2021-N-1309 | Reference 157 Johnson Sexual and Gender Minority US Youth Tobacco Use 2019 | Supporting & Related Material | Background Material | 2022-05-04T04:00:00Z | 2022 | 5 | 2022-05-04T16:50:22Z | 0 | 0 | 09000064850275d5 | |||
| FDA-2021-N-1309-0157 | FDA | None FDA-2021-N-1309 | Reference 154 Wang Tobacco Use Among Middle and High School 2018 | Supporting & Related Material | Background Material | 2022-05-04T04:00:00Z | 2022 | 5 | 2022-05-04T16:45:15Z | 0 | 0 | 0900006485027a02 | |||
| FDA-2021-N-1309-0191 | FDA | None FDA-2021-N-1309 | Reference 189 Wang Analysis of Pyrolysis Characteristics 2021 | Supporting & Related Material | Background Material | 2022-05-04T04:00:00Z | 2022 | 5 | 2022-05-04T17:27:24Z | 0 | 0 | 0900006485028fe2 | |||
| FDA-2021-N-1309-0188 | FDA | None FDA-2021-N-1309 | Reference 186 Baker The Effect of Tobacco Ingredients on Smoke Chemistry 2004 | Supporting & Related Material | Background Material | 2022-05-04T04:00:00Z | 2022 | 5 | 2022-05-04T17:27:00Z | 0 | 0 | 0900006485029004 | |||
| FDA-2021-N-1309-0167 | FDA | None FDA-2021-N-1309 | Reference 164 Corey Little Filtered Cigar Cigarillo and Premium Cigar 2014 | Supporting & Related Material | Background Material | 2022-05-04T04:00:00Z | 2022 | 5 | 2022-05-04T16:51:22Z | 0 | 0 | 0900006485027a51 | |||
| FDA-2021-N-1309-0174 | FDA | None FDA-2021-N-1309 | Reference 171 Blosnich Disparities in Smoking and Acute Respiratory 2010 | Supporting & Related Material | Background Material | 2022-05-04T04:00:00Z | 2022 | 5 | 2022-05-04T17:15:56Z | 0 | 0 | 0900006485027e75 | |||
| FDA-2021-N-1309-0189 | FDA | None FDA-2021-N-1309 | Reference 187 Baker The Pyrolysis of Non Volatile Tobacco Ingredients Using 2005 | Supporting & Related Material | Background Material | 2022-05-04T04:00:00Z | 2022 | 5 | 2022-05-04T17:27:09Z | 0 | 0 | 0900006485028fe0 | |||
| FDA-2021-N-1309-0173 | FDA | None FDA-2021-N-1309 | Reference 170 Schuler Sexual Minority Substance Use Disparities 2020 | Supporting & Related Material | Background Material | 2022-05-04T04:00:00Z | 2022 | 5 | 2022-05-04T17:15:48Z | 0 | 0 | 0900006485027631 | |||
| FDA-2021-N-1309-0278 | FDA | None FDA-2021-N-1309 | Reference 275 Hamad Association of Low Socioeconomic Status 2020 | Supporting & Related Material | Background Material | 2022-05-04T04:00:00Z | 2022 | 5 | 2022-05-04T18:07:00Z | 0 | 0 | 090000648502a277 | |||
| FDA-2021-N-1309-0283 | FDA | None FDA-2021-N-1309 | Reference 280 Prochaska Smoking Mental Illness and Public Health 2017 | Supporting & Related Material | Background Material | 2022-05-04T04:00:00Z | 2022 | 5 | 2022-05-04T18:07:37Z | 0 | 0 | 090000648502a27a | |||
| FDA-2021-N-1309-0284 | FDA | None FDA-2021-N-1309 | Reference 281 Veldhuizen Cause Specific Mortality 2014 | Supporting & Related Material | Background Material | 2022-05-04T04:00:00Z | 2022 | 5 | 2022-05-04T18:07:43Z | 0 | 0 | 090000648502a30b | |||
| FDA-2021-N-1309-0291 | FDA | None FDA-2021-N-1309 | Reference 288 Counotte Development of the Motivational System 2011 | Supporting & Related Material | Background Material | 2022-05-04T04:00:00Z | 2022 | 5 | 2022-05-04T18:08:49Z | 0 | 0 | 090000648502a3a3 | |||
| FDA-2021-N-1309-0246 | FDA | None FDA-2021-N-1309 | Reference 243 Shapiro Cigar Smoking in Men and Risk of Death 2000 | Supporting & Related Material | Background Material | 2022-05-04T04:00:00Z | 2022 | 5 | 2022-05-04T17:58:01Z | 0 | 0 | 0900006485029e12 | |||
| FDA-2021-N-1309-0237 | FDA | None FDA-2021-N-1309 | Reference 234 Ferraroni Socioeconomic Indicators Tobacco and Alcohol 1989 | Supporting & Related Material | Background Material | 2022-05-04T04:00:00Z | 2022 | 5 | 2022-05-04T17:55:24Z | 0 | 0 | 0900006485029e16 | |||
| FDA-2021-N-1309-0252 | FDA | None FDA-2021-N-1309 | Reference 249 Heineman Increased Risk of Colorectal Cancer 1994 | Supporting & Related Material | Background Material | 2022-05-04T04:00:00Z | 2022 | 5 | 2022-05-04T17:58:50Z | 0 | 0 | 0900006485029e53 | |||
| FDA-2021-N-1309-0239 | FDA | None FDA-2021-N-1309 | Reference 236 Malhotra Association Between Cigar or Pipe Smoking and Cancer 2017 | Supporting & Related Material | Background Material | 2022-05-04T04:00:00Z | 2022 | 5 | 2022-05-04T17:56:29Z | 0 | 0 | 0900006485029e0d | |||
| FDA-2021-N-1309-0271 | FDA | None FDA-2021-N-1309 | Reference 268 Van Dyke Heart Disease Death Rates Among 2018 | Supporting & Related Material | Background Material | 2022-05-04T04:00:00Z | 2022 | 5 | 2022-05-04T18:04:47Z | 0 | 0 | 090000648502a22c | |||
| FDA-2021-N-1309-0281 | FDA | None FDA-2021-N-1309 | Reference 278 Smith Smoking and Mental Illness in the US Population 2014 | Supporting & Related Material | Background Material | 2022-05-04T04:00:00Z | 2022 | 5 | 2022-05-04T18:07:22Z | 0 | 0 | 090000648502a2be | |||
| FDA-2021-N-1309-0298 | FDA | None FDA-2021-N-1309 | Reference 295 IARC Effectiveness of Tax and Price Policies 2011 | Supporting & Related Material | Background Material | 2022-05-04T04:00:00Z | 2022 | 5 | 2022-05-04T18:10:04Z | 0 | 0 | 090000648502a3e2 | |||
| FDA-2021-N-1309-0305 | FDA | None FDA-2021-N-1309 | Reference 302 Rostron Estimation of Cigarette Smoking Attributable Mortality 2014 | Supporting & Related Material | Background Material | 2022-05-04T04:00:00Z | 2022 | 5 | 2022-05-04T18:12:53Z | 0 | 0 | 0900006485035bd4 | |||
| FDA-2021-N-1309-0301 | FDA | None FDA-2021-N-1309 | Reference 298 FDA Preliminary Regulatory Impact Analysis 2022 | Supporting & Related Material | Background Material | 2022-05-04T04:00:00Z | 2022 | 5 | 2022-05-04T18:10:51Z | 0 | 0 | 0900006485045297 | |||
| FDA-2021-N-1309-0342 | FDA | None FDA-2021-N-1309 | PRIA Reference 30 TTB Tax and Fee Rates | Supporting & Related Material | Background Material | 2022-05-04T04:00:00Z | 2022 | 5 | 2022-05-04T18:20:44Z | 0 | 0 | 09000064850381f2 |
Advanced export
JSON shape: default, array, newline-delimited, object
CREATE TABLE documents (
id TEXT PRIMARY KEY,
agency_id TEXT,
docket_id TEXT REFERENCES dockets(id),
title TEXT,
document_type TEXT,
subtype TEXT,
posted_date TEXT,
posted_year INTEGER,
posted_month INTEGER,
comment_start_date TEXT,
comment_end_date TEXT,
last_modified TEXT,
fr_doc_num TEXT,
open_for_comment INTEGER,
withdrawn INTEGER,
object_id TEXT
);
CREATE INDEX idx_docs_agency ON documents(agency_id);
CREATE INDEX idx_docs_docket ON documents(docket_id);
CREATE INDEX idx_docs_date ON documents(posted_date);
CREATE INDEX idx_docs_year ON documents(posted_year);
CREATE INDEX idx_docs_type ON documents(document_type);
CREATE INDEX idx_docs_frnum ON documents(fr_doc_num);
CREATE INDEX idx_docs_comment_end ON documents(comment_end_date) WHERE comment_end_date IS NOT NULL AND withdrawn = 0;